Lexicon Pharmaceuticals LXRX Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent.
The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lexicon Pharmaceuticals's operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lexicon Pharmaceuticals's operating lease ROU assets?
- Lexicon Pharmaceuticals (LXRX) reported operating lease ROU assets of 10.5% in Q1 2026.
- How has Lexicon Pharmaceuticals's operating lease ROU assets changed year-over-year?
- Lexicon Pharmaceuticals's operating lease ROU assets increased by 8.2% year-over-year, from 9.7% to 10.5%.
- What is the long-term trend for Lexicon Pharmaceuticals's operating lease ROU assets?
- Over 3 years (2022 to 2025), Lexicon Pharmaceuticals's operating lease ROU assets has grown at a -99.7% compound annual growth rate (CAGR), from 640,700,000% to 10.5%.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.